Literature DB >> 15885186

[Drugs of abuse, protein phosphatases, and ERK pathway].

Emmanuel Valjent, Denis Hervé, Jean-Antoine Girault.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885186     DOI: 10.1051/medsci/2005215453

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


× No keyword cloud information.
  9 in total

1.  A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Authors:  Padmanabhan Mannangatti; Kamalakkannan NarasimhaNaidu; Mohamad Imad Damaj; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

2.  Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase.

Authors:  Padmanabhan Mannangatti; Obulakshmi Arapulisamy; Toni S Shippenberg; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

3.  Effects of environmental enrichment on ERK1/2 phosphorylation in the rat prefrontal cortex following nicotine-induced sensitization or nicotine self-administration.

Authors:  Adrian M Gomez; Wei-Lun Sun; Narasimha M Midde; Steven B Harrod; Jun Zhu
Journal:  Eur J Neurosci       Date:  2014-10-18       Impact factor: 3.386

4.  Therapeutic targeting of "DARPP-32": a key signaling molecule in the dopiminergic pathway for the treatment of opiate addiction.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Jessica L Reynolds; Bindukumar B Nair; Donald E Sykes; Zihua Hu; Adela Bonoiu; Hong Ding; Paras N Prasad; Stanley A Schwartz
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

Review 5.  Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.

Authors:  Wei-Lun Sun; Pamela M Quizon; Jun Zhu
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-17       Impact factor: 3.622

6.  Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons.

Authors:  Adela C Bonoiu; Supriya D Mahajan; Hong Ding; Indrajit Roy; Ken-Tye Yong; Rajiv Kumar; Rui Hu; Earl J Bergey; Stanley A Schwartz; Paras N Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

7.  Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.

Authors:  Thomas Del'guidice; Morgane Lemasson; Jean-Martin Beaulieu
Journal:  Front Neuroanat       Date:  2011-09-06       Impact factor: 3.856

8.  Prefrontal microRNA-221 Mediates Environmental Enrichment-Induced Increase of Locomotor Sensitivity to Nicotine.

Authors:  Adrian M Gomez; Diego Altomare; Wei-Lun Sun; Narasimha M Midde; Hao Ji; Michael Shtutman; Jill R Turner; Kim E Creek; Jun Zhu
Journal:  Int J Neuropsychopharmacol       Date:  2015-08-01       Impact factor: 5.176

9.  Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D1 Receptor Signaling.

Authors:  Maria-Daniela Cirnaru; Chiara Melis; Tomas Fanutza; Swati Naphade; Kizito-Tshitoko Tshilenge; Brian S Muntean; Kirill A Martemyanov; Joshua L Plotkin; Lisa M Ellerby; Michelle E Ehrlich
Journal:  eNeuro       Date:  2019-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.